Clovis Oncology, Inc. (CLVS) [Rocket]

Overview

Clovis Oncology, Inc. (CLVS)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Price:	$3.14			Metrics
OS:	145.0	M
Market cap:	$455	M
Net debt:	$380	M
EV:	$835	M

TTM Valuation
EBITDA	($199)	M
EBIT	($207)	M
EPS	($1.82)

Recent News + Filings (All items)

Date Filed	Type	Description
07/18/2023	EFFECT	Form EFFECT - Notice of Effectiveness:
07/11/2023	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
07/11/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	148.8	164.5	143.0	95.4	55.5	396.5	0.0	13.6
Revenue growth	-9.6%	15.0%	49.9%	71.8%	-86.0%		-100.0%
Cost of goods sold	23.6	37.5	25.0	0.0	0.0	0.0	-389.3	0.0
Gross profit	125.2	127.0	118.0	95.4	55.5	396.5	389.3	13.6
Gross margin	84.1%	77.2%	82.5%	100.0%	100.0%	100.0%		100.0%
Selling, general and administrative	128.4	163.9	182.8	175.8	138.9	40.7	30.5	21.5
Research and development	186.6	257.7	283.1	231.3	142.5	251.1	269.3	137.7
EBIT	-220.3	-337.3	-367.3	-333.8	-343.1	-268.2	-287.2	-155.1
EBIT margin	-148.1%	-205.0%	-256.8%	-350.0%	-618.1%	-67.7%		-1138.0%
Pre-tax income	-264.9	-369.8	-398.6	-367.4	-350.0	-381.2	-381.9	-157.7
Income taxes	-0.4	-0.5	1.8	0.6	-3.6	-32.0	-29.1	2.3
Tax rate	0.2%	0.1%			1.0%	8.4%	7.6%
Net income	-264.5	-369.2	-400.4	-368.0	-346.4	-349.1	-352.9	-160.0
Net margin	-177.8%	-224.4%	-280.0%	-385.8%	-624.0%	-88.1%		-1174.5%

Diluted EPS	($2.29)	($4.38)	($7.43)	($7.07)	($7.36)	($9.07)	($9.79)	($4.72)
Shares outstanding (diluted)	115.5	84.3	53.9	52.1	47.0	38.5	36.0	33.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy